The Asia-Pacific biosurgery market is estimated to project a CAGR of 7.46% during the forecast period, 2021-2028. The increasing number of surgical procedures, the development of new products, and the rising burden of chronic disorders drive market growth.
ASIA-PACIFIC BIOSURGERY MARKET FORECAST 2021-2028
Asia Pacific Market by Product ( Hemostatic Agents, Bone-graft Substitutes ( Synthetic Graft Extenders, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Cell-based Matrices ) Surgical Sealing Agents ( Natural, Synthetic ) Soft-tissue Management ( Synthetic Mesh/patch, Natural Mesh/patch ) Anti-adhesive Agents, Staple Line Reinforcement ) Market by Source Type ( Natural, Synthetic ) Market by Application ( Orthopedic Surgery, Cardio and Thoracic Surgery, Neuro and Spine Surgery, General Surgery, Other Applications ) by Geography.
The Asia-Pacific biosurgery market is estimated to project a CAGR of 7.46% during the forecast period, 2021-2028. The increasing number of surgical procedures, the development of new products, and the rising burden of chronic disorders drive market growth.
To learn more about this report, request a free sample copy
The Asia-Pacific biosurgery market growth is accredited to Australia & New Zealand, Japan, Vietnam, China, Indonesia, Thailand, South Korea, India, and Rest of Asia-Pacific. China is one of the major healthcare industries in the Asia-Pacific region. The market growth is driven by the growing number of surgical procedures and the rising pool of chronic disease patients. As per the National Bureau of Statistics of China, around 165,316 surgical procedures were registered in Qinghai Province, China, in 2018. Almost 4,568,754 new cancer cases were reported in 2020 as per Globocan, with 3,002,899 deaths. Cancer needs surgery for tumor removal. Moreover, the prevalence of cardiovascular diseases has been continuously rising. According to a 2018 report published in the Journal of Geriatric Cardiology, around 2 in 5 deaths are attributed to CVD.
In South Korea, the increasing number of surgical procedures, the rising burden of chronic disorders, and the development of new products fuel market growth. As per the World Ageing Population, almost 2376 thousand people constitute the aged population (65 and above) as of 2019. The elderly population is at higher risk of chronic disease, needing surgery, thereby increasing the demand for biosurgery products. Moreover, South Korea has the presence of well-established companies, which is projected to positively impact the market growth. For instance, Samyan Biopharm, based in South Korea, provides extensive product lines related to Biosurgery products like Q-Guard Topical Hemostatic Dressing and SurgiGuard. Such factors propel market growth in these countries.
CSL Limited offers biotherapies and operates globally through its human health businesses like Seqirus, CSL Plasma, and CSL Behring. The company operates in over 35 countries with headquarters in Melbourne, Victoria, Australia.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- PREVALENCE OF GERIATRIC POPULATION
- ADVANCEMENTS IN TECHNOLOGY
- INCIDENCE OF MUSCULOSKELETAL DISORDERS
- SURGE IN RESEARCH AND DEVELOPMENT
- KEY RESTRAINTS
- HIGH COST OF SURGERIES
- RISK ASSOCIATED WITH IMMUNE RESPONSE
- GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON BIOSURGERY MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- KEY BUYING CRITERIA
- KEY INSIGHTS
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY PRODUCT
- HEMOSTATIC AGENTS
- BONE-GRAFT SUBSTITUTES
- SYNTHETIC GRAFT EXTENDERS
- DEMINERALIZED BONE MATRIX
- BONE MORPHOGENETIC PROTEINS
- CELL-BASED MATRICES
- SURGICAL SEALING AGENTS
- NATURAL
- SYNTHETIC
- SOFT-TISSUE MANAGEMENT
- SYNTHETIC MESH/PATCH
- NATURAL MESH/PATCH
- ANTI-ADHESIVE AGENTS
- STAPLE LINE REINFORCEMENT
- MARKET BY SOURCE TYPE
- NATURAL
- SYNTHETIC
- MARKET BY APPLICATION
- ORTHOPEDIC SURGERY
- CARDIO AND THORACIC SURGERY
- NEURO AND SPINE SURGERY
- GENERAL SURGERY
- OTHER APPLICATIONS
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLER
- KEY CHALLENGE
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- AUSTRALIA & NEW ZEALAND
- SOUTH KOREA
- THAILAND
- INDONESIA
- VIETNAM
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- BAXTER INTERNATIONAL INC
- B BRAUN MELSUNGEN AG
- BECTON, DICKINSON AND COMPANY (C R BARD)
- BETATECH MEDICAL
- CSL LIMITED
- CRYOLIFE INC
- ETHICON INC (JOHNSON & JOHNSON)
- INTEGRA LIFESCIENCES HOLDINGS CORPORATION
- MEDTRONIC PLC
- RTI SURGICAL
- SANOFI
- SMITH & NEPHEW PLC
- STRYKER CORPORATION
- WRIGHT MEDICAL GROUP NV
- ZIMMER BIOMET HOLDINGS INC
- KEY STRATEGIC DEVELOPMENTS
TABLE LIST
TABLE 1: MARKET SNAPSHOT – BIOSURGERY
TABLE 2: ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: LEADING PLAYERS OPERATING IN ASIA-PACIFIC BIOSURGERY MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
FIGURE LIST
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, IN 2020
FIGURE 6: ASIA-PACIFIC BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, IN 2020
FIGURE 21: ASIA-PACIFIC BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, IN 2020
FIGURE 24: ASIA-PACIFIC BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 30: CHINA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: JAPAN BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: INDIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: SOUTH KOREA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: THAILAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: INDONESIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: VIETNAM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLER
- KEY CHALLENGE
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- AUSTRALIA & NEW ZEALAND
- SOUTH KOREA
- THAILAND
- INDONESIA
- VIETNAM
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY SOURCE TYPE
- NATURAL
- SYNTHETIC
- MARKET BY APPLICATION
- ORTHOPEDIC SURGERY
- CARDIO AND THORACIC SURGERY
- NEURO AND SPINE SURGERY
- GENERAL SURGERY
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.